Formation of renal stones requires supersaturation (SS) high enough to
induce crystallization; such a SS is referred to as the upper limit o
f metastability (ULM). The ULM for calcium oxalate (CaOx) or calcium p
hosphate can be measured by adding oxalate or calcium to urine, respec
tively, and noting the point at which overt crystallization occurs as
evidenced by clouding. In principle, the urine should be more prone to
form stone crystals as its SS approaches the ULM, and the SS ULM dist
ance has been used as an index of stone forming potential. In addition
, one would expect the ULM and initial SS to be unrelated, as the star
ting urine SS has no apparent link to the amount of calcium or oxalate
that urine can dissolve without leading to crystal formation. However
, in rats, we have found a surprising correlation between ULM and SS,
such that ULM appears to rise with initial SS, for CaOx, and, to a les
ser extent, for brushite (Br), a typical calcium phosphate initial pha
se. In this study, we measured CaOx and Br ULM, and SS, in urine of 50
patients and 11 normal people. to determine if ULM and SS were correl
ated, as in rats, and to explore the relationship between SS and ULM.
We found the same dependence of ULM on SS as in rats, for both CaOx an
d Br, and found no differences between patients and normal people with
respect to this dependency. However, for Br, patients showed a lower
ULM than normals, but the same initial SS, meaning that patients were
closer to their crystal formation threshold than normals. Treatments f
or stones had no apparent effect on the SS-ULM dependency. We conclude
that in humans, as in rats, ULM is related to initial SS, and that th
is relationship is the same in patients as in normals for CaOx, but sh
ifted in a stone forming direction for Br among patients. The ULM-SS i
nteraction is unaffected by contemporary conventional stone treatments
, and is more marked for CaOx than Br. The mechanisms of the dependenc
e are unknown. The smaller difference between ULM and initial SS for B
r in patients than normal supports prior evidence suggesting a defect
in stone patients that could lead to calcium phosphate crystallization
, subsequent nucleation of CaOx, and stone disease.